Results 101 to 110 of about 4,566 (176)
Tumor mutational burden (TMB) and T‐cell receptor (TCR) might predict the response to immunotherapy in patients with non–small cell lung cancer (NSCLC). However, the predictive value of the combination of TMB and TCR was not clear.
Yalun Li +12 more
doaj +1 more source
Striking differences of LDL receptor-related protein 1B expression in mouse and human
The low density lipoprotein (LDL) receptor-related protein 1B (LRP1B) is a member of the expanding LDL receptor family, and is closely related to LRP.
Li, Yonghe, Bu, Guojun, Lu, Wenyan
core +1 more source
Epigenetic Signatures in Ovarian Cancer to Determine Potential Diagnostic/Prognostic Biomarkers
Objective: Identification of methylation patterns in cell-free DNA (cfDNA) provides a non-invasive methodology for discovering critical biomarkers that facilitate detection and prognostic evaluation of ovarian cancer (OC).
Tuba Gunel +5 more
doaj +1 more source
The LDL receptor-related protein 1B (LRP1B) is a putative tumor suppressor homologous to LRP1. Both LRP1 and LRP1B contain cytoplasmic tails with several potential endocytosis motifs.
Li, Yonghe +5 more
core +1 more source
The low density lipoprotein (LDL) receptor-related protein 1B (LRP1B) is a newly identified member of the LDL receptor family that shares high homology with the LDL receptor-related protein (LRP).
Li, Yonghe +5 more
core +1 more source
LRP1b and LRP8 function in lineage commitment in the human embryo.
We measured total transcription in the inner cell mass (ICM) and the trophectoderm (TE) of the human embryo to understand the mechanisms underlying TE commitment. We describe here discovery of LRP1b and LRP8 as lineage commitment markers or lineage commitment cooperating factor in embryonic stem cells of the human embryo.
openaire +1 more source
Background: Tumor mutation burden (TMB) have been served as the most prevalent biomarkers to predict immunotherapy response. LRP1B (low-density lipoprotein receptor-related protein 1B) is frequently mutated in melanoma, non-small cell lung cancer (NSCLC)
Qian Wu (209382) +5 more
core +1 more source
Clinical Utility of Broad-Panel Profiling in Non-Small Cell Lung Cancer: Pairwise Co-Mutational Gene Patterns and PD-L1 Associations Define Stage-Specific Prognosis. [PDF]
Sassorossi C +19 more
europepmc +1 more source

